Calidi Biotherapeutics files 8-K/A to add auditor consent to Jan 10 filing

Calidi Biotherapeutics, Inc.

Amendment solely adds Exhibit 23.1, consent of Marcum LLP.
No modifications to prior 8-K disclosure; no new financial or operational data.
Filing date Feb 10, 2025; original report filed Jan 10, 2025.

item 9.01

Calidi Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-005699

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.